Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cancer

Boogie Fever star Foster Sylvers dead aged 64 after cancer battle

The former child singer who rose to fame with Misdemeanor and later enjoyed chart-topping success with family group The Sylvers has died aged 64.

BANG Premier

Pennsylvania woman falsely claimed she had cancer, defrauded family and friends of thousands of dollars to fund trips to Australia

A Pennsylvania woman accused of pretending to have terminal brain cancer to collect thousands of dollars from friends, family members and supporters is now being sought by the FBI, years after she was charged in a fraud scheme.

The Times of India

Multiple failures caused mould contamination in cancer wards at the Mater for years

Documents reveal the extent of the 'systemic problem'.

Newcastle Herald

From analysis to the latest developments in health,
read the most diverse news in one place.

Newly developed drug helps extend the lives of lung cancer patients in trial

IN FULL

The Independent UK

Pancreatic cancer breakthrough as pill almost doubles survival time for patients

IN FULL

The Independent UK

Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage study

The study, which followed patients for over five ‌years, found that those ⁠who received ⁠the regimen were nine times more likely to have little to no detectable cancer in the prostate at the time of surgery compared with those given testosterone-blocking therapy alone.

The Economic Times

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer

Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung cancer

The Independent UK

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

The Guardian - UK

World faces cancer workforce crisis with 100m staff shortfall, report warns

Researchers say healthcare systems could be overwhelmed by 2050 as global burden of disease continues to rise

The Guardian - UK

New cancer pill almost doubles survival time for pancreatic patients during trial

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

The Independent UK

New pill helps double survival time for people with advanced pancreatic cancer

The drug also had fewer side-effects when compared to chemotherapy, according to a trial.

Evening Standard

Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, even in patients who previously received Novartis' Pluvicto. Response rates were higher in patients without prior Pluvicto treatment. Larger trials are planned to assess side effects. Novartis is increasing its focus on radioligand…

The Economic Times

New cancer jab returns ‘unprecedented’ results in major clinical trial

IN FULL

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

'Unprecedented' cancer jab can destroy whole tumours

An injection that can eradicate tumours in patients with very limited treatment options has been hailed by cancer specialists after an international trial.

The Independent UK

Doctors hail cancer injection that can destroy entire tumors

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

The Independent UK

Cancer jab eradicates entire tumours in breakthrough trial

It shrank the tumours for 42 per cent of patients in the Institute of Cancer Research

Evening Standard

Cancer jabs destroy whole tumours in treatment-resistant cases, trial shows

Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Cancer jab can eradicate entire tumours in patients, trial shows

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

The Independent UK

Promising bowel cancer drug gives patient ‘new lease of life’

IN FULL

The Independent UK

New bowel cancer drug halts tumour growth in nine out of 10 patients

The drug works by triggering the ‘death’ of cancer cells while largely sparing healthy tissue

Evening Standard

Targeted drug shows promise for people with advanced bowel cancer in early trial

One patient taking part in the trial said the therapy has given her a ‘new lease of life’.

The Independent UK

Cancer-detecting blood test ‘feasible at scale’ on NHS

IN FULL

The Conversation

Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger adults. In fact, the growing incidence of colorectal cancer in people under age 50 helped drive the American Cancer Society’s 2018 decision to recommend lowering the recommended age for average-risk screening from…

The Guardian - UK

Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnoses

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Hunter New England Health

63 stories

ICR

61 stories

American Cancer Society

The Royal Marsden NHS Foundation Trust

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.